Literature DB >> 28437540

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.

Weihua Zhao1, David R Beers1, Kristopher G Hooten2, Douglas H Sieglaff3, Aijun Zhang4, Shanker Kalyana-Sundaram5, Christopher M Traini5, Wendy S Halsey5, Ashley M Hughes5, Ganesh M Sathe5, George P Livi5, Guo-Huang Fan6, Stanley H Appel1.   

Abstract

Importance: Amyotrophic lateral sclerosis (ALS) is a common adult-onset neurodegenerative disease characterized by selective loss of upper and lower motor neurons. Patients with ALS have persistent peripheral and central inflammatory responses including abnormally functioning T cells and activated microglia. However, much less is known about the inflammatory gene profile of circulating innate immune monocytes in these patients. Objective: To characterize the transcriptomics of peripheral monocytes in patients with ALS. Design, Setting, and Participants: Monocytes were isolated from peripheral blood of 43 patients with ALS and 22 healthy control individuals. Total RNA was extracted from the monocytes and subjected to deep RNA sequencing, and these results were validated by quantitative reverse transcription polymerase chain reaction. Main Outcomes and Measures: The differential expressed gene signatures of these monocytes were identified using unbiased RNA sequencing strategy for gene expression profiling.
Results: The demographics between the patients with ALS (mean [SD] age, 58.8 [1.57] years; 55.8% were men and 44.2% were women; 90.7% were white, 4.65% were Hispanic, 2.33% were black, and 2.33% were Asian) and control individuals were similar (mean [SD] age, 57.6 [2.15] years; 50.0% were men and 50.0% were women; 90.9% were white, none were Hispanic, none were black, and 9.09% were Asian). RNA sequencing data from negative selected monocytes revealed 233 differential expressed genes in ALS monocytes compared with healthy control monocytes. Notably, ALS monocytes demonstrated a unique inflammation-related gene expression profile, the most prominent of which, including IL1B, IL8, FOSB, CXCL1, and CXCL2, were confirmed by quantitative reverse transcription polymerase chain reaction (IL8, mean [SE], 1.00 [0.18]; P = .002; FOSB, 1.00 [0.21]; P = .009; CXCL1, 1.00 [0.14]; P = .002; and CXCL2, 1.00 [0.11]; P = .01). Amyotrophic lateral sclerosis monocytes from rapidly progressing patients had more proinflammatory DEGs than monocytes from slowly progressing patients. Conclusions and Relevance: Our data indicate that ALS monocytes are skewed toward a proinflammatory state in the peripheral circulation and may play a role in ALS disease progression, especially in rapidly progressing patients. This increased inflammatory response of peripheral immune cells may provide a potential target for disease-modifying therapy in patients with ALS.

Entities:  

Mesh:

Year:  2017        PMID: 28437540      PMCID: PMC5822209          DOI: 10.1001/jamaneurol.2017.0357

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  35 in total

1.  The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS.

Authors:  Jenny S Henkel; David R Beers; László Siklós; Stanley H Appel
Journal:  Mol Cell Neurosci       Date:  2005-12-05       Impact factor: 4.314

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Peripheral monocytes are functionally altered and invade the CNS in ALS patients.

Authors:  Lisa Zondler; Kathrin Müller; Samira Khalaji; Corinna Bliederhäuser; Wolfgang P Ruf; Veselin Grozdanov; Meinolf Thiemann; Katrin Fundel-Clemes; Axel Freischmidt; Karlheinz Holzmann; Benjamin Strobel; Patrick Weydt; Anke Witting; Dietmar R Thal; Anika M Helferich; Bastian Hengerer; Kay-Eberhard Gottschalk; Oliver Hill; Michael Kluge; Albert C Ludolph; Karin M Danzer; Jochen H Weishaupt
Journal:  Acta Neuropathol       Date:  2016-02-24       Impact factor: 17.088

4.  Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.

Authors:  Oleg Butovsky; Mark P Jedrychowski; Ron Cialic; Susanne Krasemann; Gopal Murugaiyan; Zain Fanek; David J Greco; Pauline M Wu; Camille E Doykan; Olga Kiner; Robert J Lawson; Matthew P Frosch; Nathalie Pochet; Rachid El Fatimy; Anna M Krichevsky; Steven P Gygi; Hans Lassmann; James Berry; Merit E Cudkowicz; Howard L Weiner
Journal:  Ann Neurol       Date:  2014-11-27       Impact factor: 10.422

5.  Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

Authors:  J Kuhle; R L P Lindberg; A Regeniter; M Mehling; A J Steck; L Kappos; A Czaplinski
Journal:  Eur J Neurol       Date:  2009-02-19       Impact factor: 6.089

6.  Comparison of normalization and differential expression analyses using RNA-Seq data from 726 individual Drosophila melanogaster.

Authors:  Yanzhu Lin; Kseniya Golovnina; Zhen-Xia Chen; Hang Noh Lee; Yazmin L Serrano Negron; Hina Sultana; Brian Oliver; Susan T Harbison
Journal:  BMC Genomics       Date:  2016-01-05       Impact factor: 3.969

7.  Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

Authors:  Oleg Butovsky; Shafiuddin Siddiqui; Galina Gabriely; Amanda J Lanser; Ben Dake; Gopal Murugaiyan; Camille E Doykan; Pauline M Wu; Reddy R Gali; Lakshmanan K Iyer; Robert Lawson; James Berry; Anna M Krichevsky; Merit E Cudkowicz; Howard L Weiner
Journal:  J Clin Invest       Date:  2012-08-06       Impact factor: 14.808

8.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

Authors:  L J Haverkamp; V Appel; S H Appel
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India.

Authors:  G Nagesh Babu; Alok Kumar; Ramesh Chandra; S K Puri; Jayantee Kalita; U K Misra
Journal:  Neurochem Res       Date:  2008-02-02       Impact factor: 3.996

View more
  52 in total

1.  TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes.

Authors:  Thomas J LaRocca; Andrea Mariani; Linda R Watkins; Christopher D Link
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

2.  Motor neuron disease: Proinflammatory monocytes might contribute to ALS progression.

Authors:  Ian Fyfe
Journal:  Nat Rev Neurol       Date:  2017-05-12       Impact factor: 42.937

Review 3.  Differential contribution of microglia and monocytes in neurodegenerative diseases.

Authors:  Caroline Baufeld; Elaine O'Loughlin; Narghes Calcagno; Charlotte Madore; Oleg Butovsky
Journal:  J Neural Transm (Vienna)       Date:  2017-10-23       Impact factor: 3.575

Review 4.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

Review 5.  Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases.

Authors:  Mohammadmahdi Sabahi; Asef Joshaghanian; Mahsa Dolatshahi; Parnian Jabbari; Farzaneh Rahmani; Nima Rezaei
Journal:  J Mol Neurosci       Date:  2021-03-13       Impact factor: 3.444

Review 6.  Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers.

Authors:  Björn F Vahsen; Elizabeth Gray; Alexander G Thompson; Olaf Ansorge; Daniel C Anthony; Sally A Cowley; Kevin Talbot; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2021-04-29       Impact factor: 42.937

Review 7.  Macrophage roles in peripheral nervous system injury and pathology: Allies in neuromuscular junction recovery.

Authors:  Rachel Rios; Albina Jablonka-Shariff; Curtis Broberg; Alison K Snyder-Warwick
Journal:  Mol Cell Neurosci       Date:  2021-01-08       Impact factor: 4.314

8.  Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study.

Authors:  Nayana Gaur; Elena Huss; Tino Prell; Robert Steinbach; Joel Guerra; Akash Srivastava; Otto W Witte; Julian Grosskreutz
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

9.  Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.

Authors:  Aude Chiot; Sakina Zaïdi; Charlène Iltis; Matthieu Ribon; Félix Berriat; Lorenzo Schiaffino; Ariane Jolly; Pierre de la Grange; Michel Mallat; Delphine Bohl; Stéphanie Millecamps; Danielle Seilhean; Christian S Lobsiger; Séverine Boillée
Journal:  Nat Neurosci       Date:  2020-10-19       Impact factor: 24.884

Review 10.  Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk.

Authors:  Austin P Passaro; Abraham L Lebos; Yao Yao; Steven L Stice
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.